Pharmaceuticals

Ophthalmic Drugs Market 2026–2035 growing with rising eye disorders and aging population

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Ophthalmic Drugs Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The ophthalmic drugs market size has shown robust expansion in recent years. It is anticipated to increase from $42.25 billion in 2025 to $45.24 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.1%. The historical development can be linked to factors such as an escalating aging population, a greater occurrence of glaucoma and cataract, the proliferation of ophthalmology clinics, better availability of prescription eye medicines, and the broadening of hospital pharmacy networks.

The ophthalmic drugs market is projected to experience substantial expansion in the coming years, reaching $61.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period can be attributed to advancements in sustained-release ocular drug delivery systems, heightened awareness regarding eye health, an increase in treatments for retinal disorders, augmented healthcare spending in developing nations, and the broader adoption of over-the-counter ophthalmic products. Key developments anticipated in this period include an uptick in chronic eye disorder prevalence, a heightened need for dry eye treatments, greater utilization of combination ophthalmic medications, a move towards preservative-free formulations, and the expansion of online platforms for eye medication sales.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Ophthalmic Drugs Market?

The rising incidence of ophthalmic disorders is projected to boost the expansion of the ophthalmic drug market in the future. Ophthalmic disorders are defined as conditions or illnesses impacting the eye and its associated structures, leading to vision impairment and other ocular problems. Ophthalmic drugs encompass pharmaceutical agents or medications utilized for managing eye or vision-related diseases; consequently, the growing occurrence of ophthalmic disorders elevates the need for the ophthalmic drug market. To illustrate, data from August 2023, provided by the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicated that a minimum of 2.2 billion people globally experienced near or distance vision impairment in 2023, with more than 1 billion of these cases being preventable or treatable, primarily due to refractive errors and cataracts, where intervention reached only 36% and 17%, correspondingly. This growing prevalence of ophthalmic disorders is indeed a key driver for the ophthalmic drug market.

What Major Segment Divisions Exist Within The Ophthalmic Drugs Market?

The ophthalmic drugs market covered in this report is segmented –

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

How Are Trends Shaping The Direction Of The Ophthalmic Drugs Market?

Leading companies in the ophthalmic drugs market are concentrating on developing preservative-free medications, such as preservative-free latanoprost, to offer an effective treatment solution. Preservative-free latanoprost denotes a specific formulation of the drug latanoprost, which is employed for managing conditions like glaucoma. For example, in September 2023, Thea Pharma, a US-based pharmaceutical company specializing in the commercialization of eye care products, introduced Iyuzeh (latanoprost ophthalmic solution) 0.005%. This marked the first preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, which received FDA approval in December 2022, provides an impactful treatment choice for over 60 million people globally who are affected by glaucoma.

Which Companies Are Leading Innovation In The Ophthalmic Drugs Market?

Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa

Read the full ophthalmic drugs market report here:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

What Are The Leading Geographic Regions In The Ophthalmic Drugs Market?

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in the ophthalmic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ophthalmic Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10065&type=smp

Browse Through More Reports Similar to the Global Ophthalmic Drugs Market 2026, By The Business Research Company

Ophthalmic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Ophthalmology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795